![]() |
|
|
Vol. 294, Issue 1, 296-301, July 2000
Loyola University of Chicago, Stritch School of Medicine,
Department of Pharmacology, Maywood, Illinois
Treatment with selective serotonin reuptake inhibitors induces a
desensitization of hypothalamic postsynaptic 5-hydroxytryptamine (5-HT)1A receptors in humans and rats. This study
investigated whether fluoxetine-induced desensitization is due to
overactivation of postsynaptic 5-HT1A receptors; whether
blockade of somatodendritic 5-HT1A autoreceptors
accelerates this desensitization; and whether desensitization is
associated with a reduction of Gz proteins, which couple to
5-HT1A receptors. WAY-100635 was tested at low doses
(0.03-0.3 mg/kg), which antagonize somatodendritic 5-HT1A autoreceptors in the raphe nuclei, and at a higher dose (1 mg/kg), which completely blocks postsynaptic 5-HT1A receptors.
Plasma levels of oxytocin and adrenal corticotrophic hormone
(corticotropin) were measured as peripheral indicators of hypothalamic
5-HT1A receptor function. Daily injections of fluoxetine
(10 mg/kg/day i.p.) for 2 days did not desensitize 5-HT1A
receptors but three daily injections of fluoxetine produced a partial
desensitization of the hormone responses to
(±)-8-hydroxy-2-dipropylaminoetetralin (50 µg/kg s.c.). WAY-100635
(0.03-0.3 mg/kg) did not accelerate or potentiate the
fluoxetine-induced desensitization of 5-HT1A receptors.
However, WAY-100635 at a dose that completely blocks postsynaptic
5-HT1A receptors (1.0 mg/kg) completely prevented the
fluoxetine-induced desensitization of 5-HT1A receptors.
These data demonstrate that at least 3 days of fluoxetine exposure is required to produce a homologous desensitization of hypothalamic 5-HT1A receptors. Although previous studies indicate that
injections of fluoxetine for 14 days produce a reduction of Gz protein
levels in the hypothalamus, the levels of Gz proteins were not affected by either fluoxetine or WAY-100635. Alternative mechanisms mediating the initial stages of 5-HT1A receptor desensitization could
involve post-translational modifications in the 5-HT1A
receptor-Gz protein-signaling cascade.
This article has been cited by other articles:
![]() |
C. Alexandre, D. Popa, V. Fabre, S. Bouali, P. Venault, K.-P. Lesch, M. Hamon, and J. Adrien Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J. Neurosci., May 17, 2006; 26(20): 5554 - 5564. [Abstract] [Full Text] [PDF] |
||||